{
    "symbol": "PAYS",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-11 19:24:06",
    "content": "  Such forward-looking statements include among others that our unrestricted cash, anticipated revenues and profits will be sufficient to sustain operations for the next 12 months; that the expected total revenue, gross profit margins, operating expenses, depreciation and amortization, stock-based compensation, adjusted EBITDA, plasma revenues and pharma revenues for 2022 meet our expectations; that the company will continue to post year-over-year improvements; that the company's growth prospects in plasma, pharma and other prepaid business materialize; and that the company will continue to be affected by COVID-19-related to labor shortages. Such factors include among others, the inability to continue our current growth rate in future periods; that a downturn in the economy including as a result of COVID-19 and variants as well as further government stimulus measures could reduce our customer base and demand for our products and services, which could have an adverse effect on our business, financial condition, profitability and cash flows; operating in a highly regulated environment, failure by us for business partners to comply with applicable laws and regulations, changes in the laws regulations, credit card association rules or other industry standards affecting our business; that a data security breach could dispose us to liability and protracted and costly litigation and other risk factors set forth in our Form 10-K for the year ended December 31, 2021."
}